Patient Case 2: Second-line Treatment Selection and Adverse Event Management

Video

Dr Velázquez Mañana revisits the second patient case and details the use of second-line amivantamab for the patient’s disease progression, and the panel confers about adverse event management strategies for patients taking this regimen.

Related Videos
Experts on breast cancer
Expert on GVHD
Expert on breast cancer
Experts on breast cancer
Expert on GVHD
Experts on GVHD
Expert on breast cancer
Experts on breast cancer
Expert on GVHD
Expert on GVHD
Related Content